Biomedical subjects
T L Kurt
Publications and source records attributed to T L Kurt.
The toxic village print shop.
Explore the source record for details and available documents.
The (internal) dangers of acrylic fingernails.
Explore the source record for details and available documents.
Neonatal exposure to methyl chloroform in tape remover.
Methyl chloroform (MC) is commonly used solvent found in some adhesive tape remover products used in intensive care nurseries. Since volatile substances can accumulate inside an infant incubator, we measured levels of MC following simulated use of 2 commercially available adhesive tape remover pads. Readily detectable levels of MC could be found in incubator air for several minutes. Although adult occupational neurotoxic thresholds are higher, increased toxic susceptibility of the neonate CNS indicates caution should be observed.
Rapid estimation of carboxyhemoglobin by breath sampling in an emergency setting.
Breath measurement of carbon monoxide (CO) can be rapidly performed in the emergency department setting by a reliable method that closely approximates carboxyhemoglobin. This method is helpful in the immediate determination of CO exposure for individual patients, but could serve as a valuable triage aid when large groups of patients are suspected of CO exposure. Serial CO determinations can be obtained during oxygen treatment to monitor for improvements without painful needle punctures and needless consumption of professional time and expense.
In response to Dr. May's letter.
Explore the source record for details and available documents.
Re: "Increased mortality in amateur radio operators due to lymphatic and hematopoietic malignancies".
Explore the source record for details and available documents.
Peripheral neuropathies due to toxic exposure.
Explore the source record for details and available documents.
Persistent symptoms of cholinesterase inhibiting pesticide toxicity (diazanon)
Explore the source record for details and available documents.
Accidental Kwell (lindane) ingestions.
Explore the source record for details and available documents.
Colon cancer in the automobile industry.
Explore the source record for details and available documents.
EtO requires special precautions according to a fetotoxicity study.
Explore the source record for details and available documents.
Dinitrophenol in weight loss: the poison center and public health safety.
Explore the source record for details and available documents.
Clinical and experimental neurotoxicity of 2-t-butylazo-2-hydroxy-5-methylhexane.
Seven workers developed weight loss, sensorimotor neuropathy, visual dysfunction, impaired mentation, and emotional lability shortly after the introduction of a new synthetic catalyst in a plant manufacturing reinforced bathtubs. The newly introduced catalyst, 2-t-butylazo-2-hydroxy-5-methylhexane, is shown to produce a similar syndrome in rats. Axonal degeneration of optic nerves, ascending and descending spinal tracts, and peripheral nerves appears to underlie this syndrome.
Neurologic dysfunction from exposure to 2-t-butylazo-2-hydroxy-5-methylhexane (BHMH): a new occupational neuropathy.
Seven cases of subacute central and peripheral neurologic dysfunction developed in 18 workers employed in the manufacture of reinforced plastic bathtubs. Cases were characterized by weight loss, dizziness, paresthesias, muscle weakness, incontinence, memory loss, and loss of peripheral, color, and night vision. Neuropathies began distally, involved both sensory and motor function, and were associated with prolonged sensory latency, muscle fibrillation, and reduced numbers of functioning motor units. One patient developed posterior lenticular cataracts. Slow improvement occurred on removal from exposure, but residual neuropathies persisted for as long as two years. Epidemiologic investigation disclosed that the first case developed approximately two weeks after introduction of a new plastic foaming agent, 2-t-butylazo-2-hydroxy-5-methylhexane (BHMH). All cases occurred in workers exposed directly to BHMH. No new cases developed after use of BHMH was discontinued. A survey of the firm which produced BHMH and of 68 user firms found two additional clusters of mild neuropathy which may have been caused by BHMH. BHMH was withdrawn from distribution following discovery of these cases. Subsequently, BHMH has been shown in rats to be a potent neurotoxin. Adequate premarket testing could have averted this outbreak.
Some personal health problems can be mistaken for job-related.
Explore the source record for details and available documents.